View in EDS PDF Full Text

Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies.

Saved in:
Bibliographic Details
Title: Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies.
Authors: Singh H; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Srour SA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., McCarty J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Dai C; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Gaballa MR; Cellular Therapy Program and Bone Marrow Transplant Unit, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, United States., Ammari M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Olivares S; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Huls H; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., De Groot E; Alaunos Therapeutics, Boston, MA, United States., Marin D; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Petropoulos D; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Olson AL; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Anderlini P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Im JS; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Khouri I; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hosing CM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Cooper LJN; Alaunos Therapeutics, Boston, MA, United States., Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Source: Frontiers in immunology [Front Immunol] 2022 Nov 10; Vol. 13, pp. 1032397. Date of Electronic Publication: 2022 Nov 10 (Print Publication: 2022).
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36439104
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Singh+H%22">Singh H</searchLink>; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Srour+SA%22">Srour SA</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Milton+DR%22">Milton DR</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22McCarty+J%22">McCarty J</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Dai+C%22">Dai C</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Gaballa+MR%22">Gaballa MR</searchLink>; Cellular Therapy Program and Bone Marrow Transplant Unit, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Ammari+M%22">Ammari M</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Olivares+S%22">Olivares S</searchLink>; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Huls+H%22">Huls H</searchLink>; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22De+Groot+E%22">De Groot E</searchLink>; Alaunos Therapeutics, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Marin+D%22">Marin D</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Petropoulos+D%22">Petropoulos D</searchLink>; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Olson+AL%22">Olson AL</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Anderlini+P%22">Anderlini P</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Im+JS%22">Im JS</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Khouri+I%22">Khouri I</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Hosing+CM%22">Hosing CM</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Rezvani+K%22">Rezvani K</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Champlin+RE%22">Champlin RE</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Shpall+EJ%22">Shpall EJ</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Cooper+LJN%22">Cooper LJN</searchLink>; Alaunos Therapeutics, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Kebriaei+P%22">Kebriaei P</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Nov 10; Vol. 13, pp. 1032397. <i>Date of Electronic Publication: </i>2022 Nov 10 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36439104
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2022.1032397
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1032397
    Titles:
      – TitleFull: Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Singh H
      – PersonEntity:
          Name:
            NameFull: Srour SA
      – PersonEntity:
          Name:
            NameFull: Milton DR
      – PersonEntity:
          Name:
            NameFull: McCarty J
      – PersonEntity:
          Name:
            NameFull: Dai C
      – PersonEntity:
          Name:
            NameFull: Gaballa MR
      – PersonEntity:
          Name:
            NameFull: Ammari M
      – PersonEntity:
          Name:
            NameFull: Olivares S
      – PersonEntity:
          Name:
            NameFull: Huls H
      – PersonEntity:
          Name:
            NameFull: De Groot E
      – PersonEntity:
          Name:
            NameFull: Marin D
      – PersonEntity:
          Name:
            NameFull: Petropoulos D
      – PersonEntity:
          Name:
            NameFull: Olson AL
      – PersonEntity:
          Name:
            NameFull: Anderlini P
      – PersonEntity:
          Name:
            NameFull: Im JS
      – PersonEntity:
          Name:
            NameFull: Khouri I
      – PersonEntity:
          Name:
            NameFull: Hosing CM
      – PersonEntity:
          Name:
            NameFull: Rezvani K
      – PersonEntity:
          Name:
            NameFull: Champlin RE
      – PersonEntity:
          Name:
            NameFull: Shpall EJ
      – PersonEntity:
          Name:
            NameFull: Cooper LJN
      – PersonEntity:
          Name:
            NameFull: Kebriaei P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 11
              Text: 2022 Nov 10
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1